September 24, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Nipro Introduces World's Smallest Blood Glucose Meter
 

Tokyo, Dec 27, 2004 (JCN) - Nipro (TSE: 8086), a leading Japanese medical device manufacturer, launched FreeStyle Flash, a blood glucose meter designed for self-monitoring, on December 22.

Based on the company's existing model FreeStyle, the new product is smaller (measuring 40.6x76.2x20.3mm and weighing about 40g) than the FreeStyle and can complete measuring faster. The unit can measure the glucose level in about 7 seconds. The alarm function notifies the user of time to measure four times a day.

The portable meter is expected to improve the convenience and quality of life of diabetic patients.

By Dale Hug Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Nipro Corporation News  
  Nipro Acquires Sales Business for Diabetes Testing Supplies  (Sept 2, 2010)
  Nipro Annual Report to Shareholders, 'Leap Higher and Further'  (Dec 13, 2006)
  Nipro Announces Acquisition of Cardiopulmonary System-related Business Segment from Edwards Lifesciences Brazil-based Affiliate  (Aug 9, 2006)
  Nipro Releases Patient Movement Detector for Preventing Accidents  (Nov 16, 2005)
  Nipro Releases Safety Disposable Plastic Needles for Pharmaceutical Preparations  (June 17, 2005)
  Nipro to Purchase Dainippon Ink and Chemicals' Extracorporeal Membrane Oxygenation Business  (Apr 5, 2005)
  Nipro Introduces World's Smallest Blood Glucose Meter  (Dec 27, 2004)



 Recent  Medical News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Medical news...

 Recent  Medical News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)